Yazen Health
PrivateLast Round
VC Round
Oct 8, 2026
Total Funding Raised
$32.63M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Yazen Health operates in Healthcare & Life Sciences and is based in Lund. Its latest recorded funding round was a VC Round in October 2026.
Yazen Health is a digital health company that provides a platform for obesity treatment, combining medical weight loss medication with lifestyle coaching from a multidisciplinary team of doctors, dietitians, psychologists, and personal trainers.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Subscription Commerce, Mental Health, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yazen Health Comparables
Compare Yazen Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Embla | 86% | |
| Manual | 84% | |
| Voy | 84% |
For institutional investors. Book with your work email.
Yazen Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 8, 2026 | ||||
| Debt | Feb 11, 2026 | ||||
| Series A | Nov 4, 2024 | ||||
| Seed | Aug 30, 2023 | ||||
| Accelerator | May 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Yazen Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aggregate Media | Series A |
| Helsana HealthInvest | Series A |
| Luminar Ventures | Series A, Seed |
| Yabeo Capital | Series A |
| Evli Growth Partners | VC Round, Series A |
| Verdane | VC Round |
| HSBC Innovation Banking | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2026
$56M round led by Verdane.
- Mar 1, 2026
Named best weight loss treatment of the year in Europe 2025.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 8, 2026
Yazen Health AB receives $56M in a SEK 500 million funding round led by Verdane, with participation from previous lead investor Evli Growth Partners, to expand obesity care across Europe in Oct '26.
For institutional investors. Book with your work email.
Yazen Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Yazen Health's valuation, stock price, and market status.
Is Yazen Health a public or private company?
Yazen Health is a private company.
What is the current stock price of Yazen Health?
Yazen Health is a private company, so its shares have no public market price. Caplight tracks Yazen Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Yazen Health worth (valuation)?
Valuation information for Yazen Health is not publicly available.
Can I buy Yazen Health stock?
Yazen Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Yazen Health's last funding round?
Yazen Health's most recent funding round was VC Round on October 8, 2026.
Who are the main investors in Yazen Health?
Key investors in Yazen Health include Helsana HealthInvest, Luminar Ventures, Evli Growth Partners, Verdane, HSBC Innovation Banking.
Will Yazen Health IPO soon?
No public IPO plans have been announced for Yazen Health.
How can I track Yazen Health secondary market activity?
Caplight tracks bids, offers, and trades in Yazen Health's shares on secondary markets.